Page last updated: 2024-08-23
1-deoxynojirimycin and paclitaxel
1-deoxynojirimycin has been researched along with paclitaxel in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, C; Liu, J; Tang, J; Wu, F | 1 |
Fujisawa, T; Hayakawa, T; Ishii, K; Ishitsuka, R; Ito, K; Kobayashi, T; Makino, A; Matsuo, H; Murate, M; Suzuki, M; Suzuki, Y | 1 |
Other Studies
2 other study(ies) available for 1-deoxynojirimycin and paclitaxel
Article | Year |
---|---|
Study on the synthesis and biological activities of α-substituted arylacetates derivatives.
Topics: Acetates; alpha-Glucosidases; Animals; Antineoplastic Agents; Cell Line, Tumor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Neoplasms; Rats; Solanaceous Alkaloids; Structure-Activity Relationship | 2016 |
D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
Topics: 1-Deoxynojirimycin; 4-Chloro-7-nitrobenzofurazan; Cells, Cultured; Ceramides; Cholesterol; Endosomes; Enzyme Activation; Fibroblasts; Glucosyltransferases; Homeostasis; Humans; Lipase; Lysophospholipids; Membrane Microdomains; Monoglycerides; Morpholines; Neuroblastoma; Paclitaxel; Stereoisomerism; Sterol Esterase | 2006 |